DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses

Radiotherapy resistance is one of the major factors limiting the efficacy of radiotherapy in lung cancer patients. The extensive investigations indicate the diversity in the mechanisms underlying radioresistance. Here, we revealed that DNA damage binding protein 2 (DDB2) is a potential regulator in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Tumour Biol
Hlavní autoři: Zou, Ning, Xie, Guozhen, Cui, Tiantian, Srivastava, Amit Kumar, Qu, Meihua, Yang, Linlin, Wei, Shaozhong, Zheng, Yanfang, Wang, Qi-En
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528175/
https://ncbi.nlm.nih.gov/pubmed/27553023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13277-016-5203-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky